AIG
FDMT icon

American International Group’s 4D Molecular Therapeutics FDMT Stock Holding History

American International Group’s Portfolio FDMT Stock Details FDMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-20,020
Closed -$638K – 950
2024
Q1 		$638K Buy
20,020
+158
+0.8% +$4.03K ﹤0.01% 1533
2023
Q4 		$402K Buy
19,862
+300
+2% +$3.95K ﹤0.01% 1793
2023
Q3 		$249K Buy
19,562
+4,361
+29% +$72.9K ﹤0.01% 2000
2023
Q2 		$275K Buy
15,201
+718
+5% +$13.2K ﹤0.01% 1994
2023
Q1 		$249K Buy
14,483
+287
+2% +$5.58K ﹤0.01% 1996
2022
Q4 		$315K Sell
14,196
-51
-0.4% -$788 ﹤0.01% 1859
2022
Q3 		$115K Buy
14,247
+202
+1% +$1.83K ﹤0.01% 2470
2022
Q2 		$98K Buy
14,045
+178
+1% +$1.73K ﹤0.01% 2608
2022
Q1 		$210K Sell
13,867
-975
-7% -$15.3K ﹤0.01% 2206
2021
Q4 		$326K Buy
14,842
+3,374
+29% +$82.7K ﹤0.01% 2074
2021
Q3 		$309K Buy
11,468
+5,964
+108% +$170K ﹤0.01% 2159
2021
Q2 		$133 Buy
5,504
+969
+21% +$29.7K ﹤0.01% 2756
2021
Q1 		$197 Buy
+4,535
New +$201K ﹤0.01% 2380

Other funds holding FDMT

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American International Group's FDMT Position: Q2 2024 in Review

American International Group sold out of 4D Molecular Therapeutics (FDMT) in Q2 2024, closing a stake of 20,020 shares — an estimated $638K sold.

American International Group first reported a position in FDMT in Q1 2021 and held it in 13 quarters. The position peaked at $638K in Q1 2024. 143 funds tracked by Wall St. Rank hold FDMT as of Q2 2024.

  • American International Group reported no remaining 4D Molecular Therapeutics position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 20,020 4D Molecular Therapeutics shares in Q2 2024, an estimated $638K.
  • American International Group first reported a position in 4D Molecular Therapeutics in Q1 2021 and held it in 13 quarters.
  • American International Group's 4D Molecular Therapeutics position peaked at $638K in Q1 2024.
  • 143 funds tracked by Wall St. Rank held 4D Molecular Therapeutics as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.